Table of Contents for the Digital Edition of Drug Information Journal - May 2008 Drug Information Journal - May 2008 Contents Safety Signals Using Proportional Reporting Ratios From Company and Regulatory Authority Databases Pharmacokinetic and Pharmacodynamic Characterization of Non-antiarrhythmic QT- Prolonging Drugs Associated With Torsades de Pointes Special Section: Benefit:Risk Evaluation in Clinical Trials Measures for Conducting Comparative Benefit:Risk Assessment A Perspective on Characterizing Benefits and Risks Derived From Clinical Trials: Can We Do More? The GSK Clinical Study Results Database: Site Utilization Metrics for a Large Public Database A Two-Stage Design for Drug Screening Trials Based on Continuous Endpoints Drug Information Availability and Preferences of Health Care Professionals in Illinois: A Pilot Survey Study Bioinformatics Modernization and the Critical Path to Improved Benefit-Risk Assessment of Drugs Patient Protection and Access to Innovative Medicinal Products in the European Union Drug Information Journal - May 2008 Drug Information Journal - May 2008 - (Page Intro) Drug Information Journal - May 2008 - Drug Information Journal - May 2008 (Page Cover1) Drug Information Journal - May 2008 - Drug Information Journal - May 2008 (Page Cover2) Drug Information Journal - May 2008 - Drug Information Journal - May 2008 (Page i) Drug Information Journal - May 2008 - Drug Information Journal - May 2008 (Page ii) Drug Information Journal - May 2008 - Drug Information Journal - May 2008 (Page iii) Drug Information Journal - May 2008 - Drug Information Journal - May 2008 (Page iv) Drug Information Journal - May 2008 - Drug Information Journal - May 2008 (Page v) Drug Information Journal - May 2008 - Drug Information Journal - May 2008 (Page vi) Drug Information Journal - May 2008 - Drug Information Journal - May 2008 (Page vii) Drug Information Journal - May 2008 - Drug Information Journal - May 2008 (Page viii) Drug Information Journal - May 2008 - Contents (Page ix) Drug Information Journal - May 2008 - Contents (Page x) Drug Information Journal - May 2008 - Contents (Page xi) Drug Information Journal - May 2008 - Contents (Page xii) Drug Information Journal - May 2008 - Contents (Page xiii) Drug Information Journal - May 2008 - Contents (Page xiv) Drug Information Journal - May 2008 - Contents (Page xv) Drug Information Journal - May 2008 - Contents (Page xvi) Drug Information Journal - May 2008 - Contents (Page xvii) Drug Information Journal - May 2008 - Contents (Page xviii) Drug Information Journal - May 2008 - Contents (Page xix) Drug Information Journal - May 2008 - Contents (Page xx) Drug Information Journal - May 2008 - Safety Signals Using Proportional Reporting Ratios From Company and Regulatory Authority Databases (Page 205) Drug Information Journal - May 2008 - Safety Signals Using Proportional Reporting Ratios From Company and Regulatory Authority Databases (Page 206) Drug Information Journal - May 2008 - Safety Signals Using Proportional Reporting Ratios From Company and Regulatory Authority Databases (Page 207) Drug Information Journal - May 2008 - Safety Signals Using Proportional Reporting Ratios From Company and Regulatory Authority Databases (Page 208) Drug Information Journal - May 2008 - Safety Signals Using Proportional Reporting Ratios From Company and Regulatory Authority Databases (Page 209) Drug Information Journal - May 2008 - Safety Signals Using Proportional Reporting Ratios From Company and Regulatory Authority Databases (Page 210) Drug Information Journal - May 2008 - Pharmacokinetic and Pharmacodynamic Characterization of Non-antiarrhythmic QT- Prolonging Drugs Associated With Torsades de Pointes (Page 211) Drug Information Journal - May 2008 - Pharmacokinetic and Pharmacodynamic Characterization of Non-antiarrhythmic QT- Prolonging Drugs Associated With Torsades de Pointes (Page 212) Drug Information Journal - May 2008 - Pharmacokinetic and Pharmacodynamic Characterization of Non-antiarrhythmic QT- Prolonging Drugs Associated With Torsades de Pointes (Page 213) Drug Information Journal - May 2008 - Pharmacokinetic and Pharmacodynamic Characterization of Non-antiarrhythmic QT- Prolonging Drugs Associated With Torsades de Pointes (Page 214) Drug Information Journal - May 2008 - Pharmacokinetic and Pharmacodynamic Characterization of Non-antiarrhythmic QT- Prolonging Drugs Associated With Torsades de Pointes (Page 215) Drug Information Journal - May 2008 - Pharmacokinetic and Pharmacodynamic Characterization of Non-antiarrhythmic QT- Prolonging Drugs Associated With Torsades de Pointes (Page 216) Drug Information Journal - May 2008 - Pharmacokinetic and Pharmacodynamic Characterization of Non-antiarrhythmic QT- Prolonging Drugs Associated With Torsades de Pointes (Page 217) Drug Information Journal - May 2008 - Pharmacokinetic and Pharmacodynamic Characterization of Non-antiarrhythmic QT- Prolonging Drugs Associated With Torsades de Pointes (Page 218) Drug Information Journal - May 2008 - Pharmacokinetic and Pharmacodynamic Characterization of Non-antiarrhythmic QT- Prolonging Drugs Associated With Torsades de Pointes (Page 219) Drug Information Journal - May 2008 - Pharmacokinetic and Pharmacodynamic Characterization of Non-antiarrhythmic QT- Prolonging Drugs Associated With Torsades de Pointes (Page 220) Drug Information Journal - May 2008 - Special Section: Benefit:Risk Evaluation in Clinical Trials (Page 221) Drug Information Journal - May 2008 - Special Section: Benefit:Risk Evaluation in Clinical Trials (Page 222) Drug Information Journal - May 2008 - Measures for Conducting Comparative Benefit:Risk Assessment (Page 223) Drug Information Journal - May 2008 - Measures for Conducting Comparative Benefit:Risk Assessment (Page 224) Drug Information Journal - May 2008 - Measures for Conducting Comparative Benefit:Risk Assessment (Page 225) Drug Information Journal - May 2008 - Measures for Conducting Comparative Benefit:Risk Assessment (Page 226) Drug Information Journal - May 2008 - Measures for Conducting Comparative Benefit:Risk Assessment (Page 227) Drug Information Journal - May 2008 - Measures for Conducting Comparative Benefit:Risk Assessment (Page 228) Drug Information Journal - May 2008 - Measures for Conducting Comparative Benefit:Risk Assessment (Page 229) Drug Information Journal - May 2008 - Measures for Conducting Comparative Benefit:Risk Assessment (Page 230) Drug Information Journal - May 2008 - Measures for Conducting Comparative Benefit:Risk Assessment (Page 231) Drug Information Journal - May 2008 - Measures for Conducting Comparative Benefit:Risk Assessment (Page 232) Drug Information Journal - May 2008 - Measures for Conducting Comparative Benefit:Risk Assessment (Page 233) Drug Information Journal - May 2008 - Measures for Conducting Comparative Benefit:Risk Assessment (Page 234) Drug Information Journal - May 2008 - A Perspective on Characterizing Benefits and Risks Derived From Clinical Trials: Can We Do More? (Page 235) Drug Information Journal - May 2008 - A Perspective on Characterizing Benefits and Risks Derived From Clinical Trials: Can We Do More? (Page 236) Drug Information Journal - May 2008 - A Perspective on Characterizing Benefits and Risks Derived From Clinical Trials: Can We Do More? (Page 237) Drug Information Journal - May 2008 - A Perspective on Characterizing Benefits and Risks Derived From Clinical Trials: Can We Do More? (Page 238) Drug Information Journal - May 2008 - A Perspective on Characterizing Benefits and Risks Derived From Clinical Trials: Can We Do More? (Page 239) Drug Information Journal - May 2008 - A Perspective on Characterizing Benefits and Risks Derived From Clinical Trials: Can We Do More? (Page 240) Drug Information Journal - May 2008 - A Perspective on Characterizing Benefits and Risks Derived From Clinical Trials: Can We Do More? (Page 241) Drug Information Journal - May 2008 - A Perspective on Characterizing Benefits and Risks Derived From Clinical Trials: Can We Do More? (Page 242) Drug Information Journal - May 2008 - A Perspective on Characterizing Benefits and Risks Derived From Clinical Trials: Can We Do More? (Page 243) Drug Information Journal - May 2008 - A Perspective on Characterizing Benefits and Risks Derived From Clinical Trials: Can We Do More? (Page 244) Drug Information Journal - May 2008 - A Perspective on Characterizing Benefits and Risks Derived From Clinical Trials: Can We Do More? (Page 245) Drug Information Journal - May 2008 - A Perspective on Characterizing Benefits and Risks Derived From Clinical Trials: Can We Do More? (Page 246) Drug Information Journal - May 2008 - The GSK Clinical Study Results Database: Site Utilization Metrics for a Large Public Database (Page 247) Drug Information Journal - May 2008 - The GSK Clinical Study Results Database: Site Utilization Metrics for a Large Public Database (Page 248) Drug Information Journal - May 2008 - The GSK Clinical Study Results Database: Site Utilization Metrics for a Large Public Database (Page 249) Drug Information Journal - May 2008 - The GSK Clinical Study Results Database: Site Utilization Metrics for a Large Public Database (Page 250) Drug Information Journal - May 2008 - The GSK Clinical Study Results Database: Site Utilization Metrics for a Large Public Database (Page 251) Drug Information Journal - May 2008 - The GSK Clinical Study Results Database: Site Utilization Metrics for a Large Public Database (Page 252) Drug Information Journal - May 2008 - A Two-Stage Design for Drug Screening Trials Based on Continuous Endpoints (Page 253) Drug Information Journal - May 2008 - A Two-Stage Design for Drug Screening Trials Based on Continuous Endpoints (Page 254) Drug Information Journal - May 2008 - A Two-Stage Design for Drug Screening Trials Based on Continuous Endpoints (Page 255) Drug Information Journal - May 2008 - A Two-Stage Design for Drug Screening Trials Based on Continuous Endpoints (Page 256) Drug Information Journal - May 2008 - A Two-Stage Design for Drug Screening Trials Based on Continuous Endpoints (Page 257) Drug Information Journal - May 2008 - A Two-Stage Design for Drug Screening Trials Based on Continuous Endpoints (Page 258) Drug Information Journal - May 2008 - A Two-Stage Design for Drug Screening Trials Based on Continuous Endpoints (Page 259) Drug Information Journal - May 2008 - A Two-Stage Design for Drug Screening Trials Based on Continuous Endpoints (Page 260) Drug Information Journal - May 2008 - A Two-Stage Design for Drug Screening Trials Based on Continuous Endpoints (Page 261) Drug Information Journal - May 2008 - A Two-Stage Design for Drug Screening Trials Based on Continuous Endpoints (Page 262) Drug Information Journal - May 2008 - Drug Information Availability and Preferences of Health Care Professionals in Illinois: A Pilot Survey Study (Page 263) Drug Information Journal - May 2008 - Drug Information Availability and Preferences of Health Care Professionals in Illinois: A Pilot Survey Study (Page 264) Drug Information Journal - May 2008 - Drug Information Availability and Preferences of Health Care Professionals in Illinois: A Pilot Survey Study (Page 265) Drug Information Journal - May 2008 - Drug Information Availability and Preferences of Health Care Professionals in Illinois: A Pilot Survey Study (Page 266) Drug Information Journal - May 2008 - Drug Information Availability and Preferences of Health Care Professionals in Illinois: A Pilot Survey Study (Page 267) Drug Information Journal - May 2008 - Drug Information Availability and Preferences of Health Care Professionals in Illinois: A Pilot Survey Study (Page 268) Drug Information Journal - May 2008 - Drug Information Availability and Preferences of Health Care Professionals in Illinois: A Pilot Survey Study (Page 269) Drug Information Journal - May 2008 - Drug Information Availability and Preferences of Health Care Professionals in Illinois: A Pilot Survey Study (Page 270) Drug Information Journal - May 2008 - Drug Information Availability and Preferences of Health Care Professionals in Illinois: A Pilot Survey Study (Page 271) Drug Information Journal - May 2008 - Drug Information Availability and Preferences of Health Care Professionals in Illinois: A Pilot Survey Study (Page 272) Drug Information Journal - May 2008 - Bioinformatics Modernization and the Critical Path to Improved Benefit-Risk Assessment of Drugs (Page 273) Drug Information Journal - May 2008 - Bioinformatics Modernization and the Critical Path to Improved Benefit-Risk Assessment of Drugs (Page 274) Drug Information Journal - May 2008 - Bioinformatics Modernization and the Critical Path to Improved Benefit-Risk Assessment of Drugs (Page 275) Drug Information Journal - May 2008 - Bioinformatics Modernization and the Critical Path to Improved Benefit-Risk Assessment of Drugs (Page 276) Drug Information Journal - May 2008 - Bioinformatics Modernization and the Critical Path to Improved Benefit-Risk Assessment of Drugs (Page 277) Drug Information Journal - May 2008 - Bioinformatics Modernization and the Critical Path to Improved Benefit-Risk Assessment of Drugs (Page 278) Drug Information Journal - May 2008 - Bioinformatics Modernization and the Critical Path to Improved Benefit-Risk Assessment of Drugs (Page 279) Drug Information Journal - May 2008 - Bioinformatics Modernization and the Critical Path to Improved Benefit-Risk Assessment of Drugs (Page 280) Drug Information Journal - May 2008 - Patient Protection and Access to Innovative Medicinal Products in the European Union (Page 281) Drug Information Journal - May 2008 - Patient Protection and Access to Innovative Medicinal Products in the European Union (Page 282) Drug Information Journal - May 2008 - Patient Protection and Access to Innovative Medicinal Products in the European Union (Page 283) Drug Information Journal - May 2008 - Patient Protection and Access to Innovative Medicinal Products in the European Union (Page 284) Drug Information Journal - May 2008 - Patient Protection and Access to Innovative Medicinal Products in the European Union (Page 285) Drug Information Journal - May 2008 - Patient Protection and Access to Innovative Medicinal Products in the European Union (Page 286) Drug Information Journal - May 2008 - Patient Protection and Access to Innovative Medicinal Products in the European Union (Page 287) Drug Information Journal - May 2008 - Patient Protection and Access to Innovative Medicinal Products in the European Union (Page 288) Drug Information Journal - May 2008 - Patient Protection and Access to Innovative Medicinal Products in the European Union (Page 289) Drug Information Journal - May 2008 - Patient Protection and Access to Innovative Medicinal Products in the European Union (Page 290) Drug Information Journal - May 2008 - Patient Protection and Access to Innovative Medicinal Products in the European Union (Page 291) Drug Information Journal - May 2008 - Patient Protection and Access to Innovative Medicinal Products in the European Union (Page 292) Drug Information Journal - May 2008 - Patient Protection and Access to Innovative Medicinal Products in the European Union (Page 293) Drug Information Journal - May 2008 - Patient Protection and Access to Innovative Medicinal Products in the European Union (Page 294) Drug Information Journal - May 2008 - Patient Protection and Access to Innovative Medicinal Products in the European Union (Page 295) Drug Information Journal - May 2008 - Patient Protection and Access to Innovative Medicinal Products in the European Union (Page 296) Drug Information Journal - May 2008 - Patient Protection and Access to Innovative Medicinal Products in the European Union (Page Cover3) Drug Information Journal - May 2008 - Patient Protection and Access to Innovative Medicinal Products in the European Union (Page Cover4) http://www.nxtbookMEDIA.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.